Across TCGA pan-cancer cohorts, GADD45B RNA is linked to patient survival in 27 of 34 cancer types, making it the most broadly survival-associated GADD45B data layer compared with 3 for mutation status.
The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher GADD45B RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated GADD45B expression acts as an unfavorable survival marker, although some lineages such as SKCM and LIHC show a favorable association.
LUSC, SKCM, and COAD are the cancer types where GADD45B RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.